120.60 USD
▲+0.48+1.83%
2026-08-03
市值
$24.45B
市盈率
15.36
EPS
7.85
股息率
—
52 周区间
75.48 – 132.60
成交量
2.08M
Beta
0.77
目标价
124.26
52W 低 75.4852W 高 132.60
价格走势
公司简介
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO fo...